KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Cash (2016 - 2025)

LifeMD's Change in Cash history spans 14 years, with the latest figure at $13.0 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 603.44% year-over-year to $13.0 million; the TTM value through Dec 2025 reached $1.8 million, down 4.13%, while the annual FY2025 figure was $1.8 million, 4.13% down from the prior year.
  • Change in Cash reached $13.0 million in Q4 2025 per LFMD's latest filing, up from -$12.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $31.9 million in Q4 2021 to a low of -$16.2 million in Q1 2022.
  • Average Change in Cash over 5 years is $1.4 million, with a median of $1.2 million recorded in 2024.
  • The largest YoY upside for Change in Cash was 18546.01% in 2021 against a maximum downside of 1472.52% in 2021.
  • A 5-year view of Change in Cash shows it stood at $31.9 million in 2021, then tumbled by 105.89% to -$1.9 million in 2022, then skyrocketed by 1050.99% to $17.9 million in 2023, then tumbled by 114.46% to -$2.6 million in 2024, then skyrocketed by 603.44% to $13.0 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Change in Cash are $13.0 million (Q4 2025), -$12.4 million (Q3 2025), and $1.8 million (Q2 2025).